Securities code: Touchstone International Medical Science Co.Ltd(688013) securities abbreviation: Touchstone International Medical Science Co.Ltd(688013) Announcement No.: 2022010 Touchstone International Medical Science Co.Ltd(688013)
Announcement on the first repurchase of shares of the company by means of centralized bidding transaction
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal responsibility for the authenticity, accuracy and integrity of its contents according to law.
Important content tips:
On March 8, 2022, Touchstone International Medical Science Co.Ltd(688013) (hereinafter referred to as “the company”) repurchased 41652 shares for the first time through the trading system of Shanghai stock exchange through centralized bidding, accounting for 0.05% of the company’s total share capital of 80000000 shares. The highest price of repurchase transaction was 22.86 yuan / share and the lowest price was 22.50 yuan / share, The total amount of funds paid is RMB 94601573 (excluding stamp duty, transaction commission and other transaction expenses).
1、 Basic information of repurchased shares
The company held the 19th meeting of the first board of directors on February 8, 2022, deliberated and approved the plan on repurchase of company shares by centralized bidding transaction, and agreed that the company would repurchase company shares by centralized bidding transaction, with the total repurchase capital not less than 50 million yuan (inclusive) and not more than 100 million yuan (inclusive), The repurchase price shall not exceed RMB 23.00/share, and the repurchase period shall be within 12 months from the date when the repurchase plan is considered and approved by the board of directors of the company. On February 22, 2022, the company’s website was www.sse.com (see details on February 22, 2022) The announcement on the plan of repurchasing the company’s shares by means of centralized bidding transaction (Announcement No.: 2022004) and the repurchase report on repurchasing the company’s shares by means of centralized bidding transaction (Announcement No.: 2022007) disclosed on the.
2、 Basic information of share repurchase for the first time
In accordance with the relevant provisions of the self regulatory guidelines for listed companies on Shanghai Stock Exchange No. 7 – share repurchase, the company’s initial share repurchase is hereby announced as follows:
On March 8, 2022, the Company repurchased 41652 shares for the first time through the trading system of Shanghai stock exchange through centralized bidding, accounting for 0.05% of the company’s total share capital of 80000000 shares. The highest price of repurchase transaction was 22.86 yuan / share, the lowest price was 22.50 yuan / share, and the total amount of funds paid was 94601573 yuan (excluding stamp duty, transaction commission and other transaction expenses). This share repurchase complies with the provisions of laws and regulations and the company’s share repurchase plan.
3、 Other matters
The company will, in strict accordance with the relevant provisions of the guidelines for self discipline supervision of listed companies on Shanghai Stock Exchange No. 7 – share repurchase and the company’s share repurchase plan, make and implement the repurchase decision according to the market conditions within the repurchase period, and timely fulfill the obligation of information disclosure according to the progress of share repurchase. Please pay attention to the investment risks. It is hereby announced.
Touchstone International Medical Science Co.Ltd(688013) board of directors March 9, 2022
